Rallybio (RLYB) Institutional Ownership → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free RLYB Stock Alerts $1.57 -0.01 (-0.63%) (As of 09:34 AM ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Rallybio (NASDAQ:RLYB)CurrentInstitutional OwnershipPercentage90.34%Number ofInstitutional Buyers(last 12 months)5TotalInstitutional Inflows(last 12 months)$4.57MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$4.57M Get RLYB Insider Trade Alerts Want to know when executives and insiders are buying or selling Rallybio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data RLYB Institutional Buying and Selling by Quarter Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry Rallybio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails1/31/2024abrdn plc1,727,067$4.13M0.0%N/A4.570% 1/12/2024SG Americas Securities LLC16,813$40K0.0%N/A0.044% 11/13/2023CHI Advisors LLC390,734$1.32M0.4%-28.0%1.034% 11/13/2023Mariner LLC408,180$1.38M0.0%-32.7%1.080% 11/8/2023 Financial Security Advisor Inc.50,278$169K0.1%N/A0.133% 9/21/2023Barclays PLC6,103$35K0.0%-36.3%0.016% Get the Latest News and Ratings for RLYB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Rallybio and its competitors with MarketBeat's FREE daily newsletter. 8/22/2023CHI Advisors LLC542,774$3.07M0.9%-28.6%1.436% 8/15/2023Caas Capital Management LP31,470$178K0.0%-80.8%0.083% 8/11/2023Sectoral Asset Management Inc.375,960$2.13M0.4%-31.9%0.995% 8/4/2023American International Group Inc.14,715$83K0.0%+62.0%0.039% 5/12/2023Sectoral Asset Management Inc.551,937$3.15M0.6%-11.0%1.450% 5/11/2023CHI Advisors LLC760,543$4.34M1.2%+4.7%1.997% 4/24/2023DekaBank Deutsche Girozentrale30,000$168K0.0%N/A0.079% 2/10/2023Sectoral Asset Management Inc.619,891$4.07M0.8%+165.6%1.935% 2/10/2023Tekla Capital Management LLC1,727,067$11.35M0.4%-0.8%5.392% 2/6/2023New Leaf Venture Partners L.L.C.3,301,603$21.69M15.7%+43.4%10.308% 2/1/2023 Canaan Partners XI LLC2,059,712$13.53M10.6%-14.5%6.431% 11/15/2022Northeast Financial Consultants Inc13,066$189K0.0%N/A0.041% 11/14/2022MetLife Investment Management LLC10,279$149K0.0%N/A0.032% 11/8/2022New York State Common Retirement Fund10,337$150K0.0%-19.8%0.032% 11/1/2022Tekla Capital Management LLC1,740,931$25.19M1.0%-9.8%5.418% 8/15/2022Laurion Capital Management LP402,000$3.04M0.0%+0.5%1.251% 8/11/2022Alps Advisors Inc.19,060$144K0.0%N/A0.059% 7/29/2022Tekla Capital Management LLC1,931,120$14.58M0.6%-12.0%6.010% 5/27/2022Walleye Capital LLC59,543$416K0.0%N/A0.185% 5/13/2022Tekla Capital Management LLC2,195,010$15.32M0.5%-4.9%6.832% 5/10/2022Sectoral Asset Management Inc.385,069$2.69M0.5%+27.8%1.198% 2/9/2022AJU IB Investment Co. Ltd.754,678$7.20M10.0%N/A2.349% 2/8/2022Northern Trust Corp61,571$588K0.0%+7.1%0.192% 2/3/2022 Canaan Partners XI LLC2,409,712$22.99M5.9%N/A7.500% 1/28/2022 Allspring Global Investments Holdings LLC2,914$27K0.0%N/A0.009% 11/16/2021Laurion Capital Management LP400,000$7.03M0.0%N/A1.245% 11/15/2021Viking Global Investors LP4,194,777$73.74M0.2%N/A13.056% 11/15/2021Sectoral Asset Management Inc527,136$9.27M0.8%N/A1.641% 11/15/2021Caas Capital Management LP10,000$176K0.0%N/A0.031% 11/12/2021New Leaf Venture Partners L.L.C.2,301,603$40.46M11.7%N/A7.163% 11/12/2021Geode Capital Management LLC69,963$1.23M0.0%N/A0.218% 11/9/2021BlackRock Inc.292,204$5.14M0.0%N/A0.909% 11/4/2021Deutsche Bank AG4,139$73K0.0%N/A0.013% 11/2/2021New York State Common Retirement Fund4,396$77K0.0%N/A0.014% This Apple-like Innovator is Revolutionizing Healthcare (Ad)AI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry(Data available from 1/1/2016 forward) RLYB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of RLYB shares? During the previous two years, 19 institutional investors and hedge funds held shares of Rallybio. The most heavily invested institutionals were New Leaf Venture Partners L.L.C. ($21.69M), Canaan Partners XI LLC ($13.53M), Tekla Capital Management LLC ($11.35M), abrdn plc ($4.13M), Laurion Capital Management LP ($3.04M), Sectoral Asset Management Inc. ($2.13M), and Mariner LLC ($1.38M).Learn more on RLYB's institutional investors. What percentage of Rallybio stock is owned by institutional investors? 90.34% of Rallybio stock is owned by institutional investors. Learn more on RLYB's institutional investor holdings. Which institutional investors have been buying Rallybio stock? Of the 13 institutional investors that purchased Rallybio stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: abrdn plc ($1.73M), New Leaf Venture Partners L.L.C. ($1M), Sectoral Asset Management Inc. ($470.35K), Walleye Capital LLC ($59.54K), Financial Security Advisor Inc. ($50.28K), CHI Advisors LLC ($34.43K), and DekaBank Deutsche Girozentrale ($30K). How much institutional buying is happening at Rallybio? Institutional investors have bought a total of 3,438,527 shares in the last 24 months. This purchase volume represents approximately $15.34M in transactions. Which Rallybio major shareholders have been selling company stock? The following institutional investors have sold Rallybio stock in the last 24 months: Tekla Capital Management LLC ($581.60K), CHI Advisors LLC ($369.81K), Canaan Partners XI LLC ($350K), Sectoral Asset Management Inc. ($243.93K), Mariner LLC ($198.30K), Caas Capital Management LP ($132.86K), and Barclays PLC ($3.47K). How much institutional selling is happening at Rallybio? Institutional investors have sold a total of 1,882,526 shares in the last 24 months. This volume of shares sold represents approximately $12.53M in transactions. Related Companies: MediciNova Major Shareholders Viveon Health Acquisition Major Shareholders Landos Biopharma Major Shareholders Celularity Major Shareholders Anebulo Pharmaceuticals Major Shareholders Lantern Pharma Major Shareholders Eagle Pharmaceuticals Major Shareholders Carisma Therapeutics Major Shareholders Immix Biopharma Major Shareholders HCW Biologics Major Shareholders This page (NASDAQ:RLYB) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceFed launches fourth dollar overhaulStansberry ResearchNew Trump BombshellThe Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rallybio Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
